Braskem Sa
BAK NYSE· Industrial Organic Chemicals
Last close · Oct 23, 2026
$1.70
KIRA · Stoqly’s AI analyst, in plain words
- Braskem Sa had $12.6B of revenue in fiscal 2025, down 11.9% on the year before. Over five years, revenue changed +2.2% a year on average.
- Its operating margin was −2.6%, down 1.2 pts: of every 100 in sales, about −3 is left after running the business.
- Braskem Sa lost $1.8B in fiscal 2025.
- Free cash flow was −$1.3B in fiscal 2025, −10.3% of revenue.
- Braskem Sa owes $7.5B more than it holds in cash, about 14.7 years of operating profit.
Market cap
—
P/E
—
Revenue
$12.6B
Net income
−$1.8B
Free cash flow
−$1.3B
Operating margin
−2.6%
Braskem Sa in 30 seconds · fiscal 2025
Are sales growing?
−11.9%
No. Sales fell 11.9% last year.
Does it make a profit?
−14.0%
No. It lost money last year.
Does profit turn into cash?
−10.3%
No. It spent more cash than it brought in.
Is debt under control?
14.7x
Heavy. Repaying its debt would take 14.7 years of operating profit.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
What Braskem Sa does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 20, 2026
- Legal name
- BRASKEM SA
- CIK
- 0001071438
Braskem Sa · BAK
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $19.6B | $18.7B | $14.1B | $14.4B | $12.6B |
| Revenue growth | 72.5% | −4.6% | −24.4% | 1.7% | −11.9% |
| Gross margin | 30.3% | 11.8% | 4.3% | 7.7% | 2.2% |
| Operating margin | 24.7% | 4.4% | −4.0% | −1.4% | −2.6% |
| Net income | $2.6B | −$65.0M | −$917M | −$2.1B | −$1.8B |
| Net margin | 13.2% | −0.3% | −6.5% | −14.6% | −14.0% |
| Diluted EPS | $6.52 | — | — | — | — |
| Cash | |||||
| Cash from operations | $2.7B | $1.7B | −$455M | $452M | −$751M |
| Capital expenditure | $634M | $938M | $907M | $698M | $553M |
| Free cash flow | $2.1B | $794M | −$1.4B | −$246M | −$1.3B |
| FCF margin | 10.8% | 4.3% | −9.6% | −1.7% | −10.3% |
| Dividends paid | $1.1B | $261M | $1.4M | $1.1M | — |
| Debt and strength | |||||
| Cash and short-term investments | $1.6B | $2.4B | $2.9B | $2.4B | $1.9B |
| Debt incl. finance leases | $6.3B | $6.8B | $8.7B | $8.6B | $9.5B |
| Shareholders' equity | $1.4B | $1.4B | $823M | −$773M | −$2.9B |
| Net debt / EBITDA | 0.8x | 2.5x | 12.0x | 8.6x | 14.7x |
| Current ratio | 1.6x | 1.4x | 1.5x | 1.3x | 0.8x |
| Interest coverage | 5.3x | 0.8x | −0.5x | −0.2x | −0.3x |
| Returns and quality | |||||
| Return on capital | 61.4% | 9.3% | −6.7% | −2.9% | −5.6% |
| Return on equity | 524.9% | −4.7% | −83.1% | −8,487.0% | — |
| Return on tangible equity | 289.5% | −4.7% | −111.4% | — | — |
| Piotroski F-score | 8 | 2 | 2 | 4 | 2 |
| Altman Z'' | — | — | 0.7 | −0.0 | −2.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Braskem Sa · BAK
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.70 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001071438). Data updated October 24, 2026. Filed in BRL under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.